Tag Archive for 'NIH'Page 2 of 2

$8.5 Billion for NIH

Late yesterday, the House and Senate reached a conference agreement on the economic stimulus package.

  • $8.5 billion for NIH, including expanding good jobs in biomedical research to study diseases such as Alzheimer’s, Parkinson’s, cancer, and heart disease.
  • $1.5 billion for NIH to renovate university research facilities and help them compete for biomedical research grants. ($10 billion total for NIH)
  • $19 billion to accelerate adoption of Health Information Technology (HIT) systems by doctors and hospitals, in order to modernize the health care system, save billions of dollars, reduce medical errors and improve quality. Strengthens Federal privacy and security law to protect personally identifiable health information from misuse and abuse.
  • $1 billion for a new Prevention and Wellness Fund. Studies have shown that investing in prevention can lower overall health care costs by billions of dollars.
  • $1.1 billion for comparative effectiveness research, to help patients and doctors determine the effectiveness of different treatments. This research will improve the quality of care.

This summary  provided from Dane Christensen of Health and Medicine Counsel of Washington.

Attached is a more comprehensive summary of the current stimulus package from the office of House Speaker Nancy Pelosi (D-CA).

National Institutes of Health’s (NIH) Advisory Committee

The National Institutes of Health’s (NIH) Advisory Committee to the Director convened for its 97th meeting, the final meeting of 2008. Following Dr. Elias Zerhouni’s resignation as NIH Director at the end of October, Dr. Raynard Kington, the Deputy NIH Director, assumed the role of Acting Director until a new Director is named. In this capacity, Dr. Kington called the meeting to order; however, he stopped short of presenting the comprehensive Director’s Report.

The meeting was in large part a recap of initiatives that the NIH prioritized this past year. Of particular interest were the presentations on NIH’s ongoing effort to enhance the peer review system and NIH’s development of recommendations to avoid conflicts of interest by its affiliated researchers. Dr. Lawrence Tabak’s presentation is entitled Enhancing Peer Review: Implementation of Recommended Actions and Dr. Sally Rockey’s presentation is Assuring Objectivity in Research: NIH and Financial Conflict of Interest.

Dr. Raynard Kington named Acting NIH Director

Following Dr. Zerhouni’s departure,  Dr. Raynard Kington has been named Acting NIH Director. Dr. Kington was appointed Deputy Director of NIH as of February 9, 2003.  Prior to this appointment, Dr. Kington had been Associate Director of NIH for Behavioral and Social Sciences Research since September 2000. In addition to this role, from January 2002 to November 2002, he served as acting director of the National Institute on Alcohol Abuse and Acoholism.